ES2086515T3 - Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos. - Google Patents

Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos.

Info

Publication number
ES2086515T3
ES2086515T3 ES91810645T ES91810645T ES2086515T3 ES 2086515 T3 ES2086515 T3 ES 2086515T3 ES 91810645 T ES91810645 T ES 91810645T ES 91810645 T ES91810645 T ES 91810645T ES 2086515 T3 ES2086515 T3 ES 2086515T3
Authority
ES
Spain
Prior art keywords
employment
procedure
obtaining
carboxylic acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91810645T
Other languages
English (en)
Spanish (es)
Inventor
Walter Dr Riess
Afred Dr Sallmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2086515T3 publication Critical patent/ES2086515T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91810645T 1990-08-23 1991-08-14 Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos. Expired - Lifetime ES2086515T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH273590 1990-08-23

Publications (1)

Publication Number Publication Date
ES2086515T3 true ES2086515T3 (es) 1996-07-01

Family

ID=4240432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91810645T Expired - Lifetime ES2086515T3 (es) 1990-08-23 1991-08-14 Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos.

Country Status (20)

Country Link
US (1) US5190947A (US07935154-20110503-C00006.png)
EP (1) EP0472501B1 (US07935154-20110503-C00006.png)
JP (1) JPH04257587A (US07935154-20110503-C00006.png)
KR (1) KR920004391A (US07935154-20110503-C00006.png)
AT (1) ATE137753T1 (US07935154-20110503-C00006.png)
AU (1) AU652951B2 (US07935154-20110503-C00006.png)
CA (1) CA2049649A1 (US07935154-20110503-C00006.png)
DE (1) DE59107784D1 (US07935154-20110503-C00006.png)
DK (1) DK0472501T3 (US07935154-20110503-C00006.png)
ES (1) ES2086515T3 (US07935154-20110503-C00006.png)
FI (1) FI96421C (US07935154-20110503-C00006.png)
GR (1) GR3019872T3 (US07935154-20110503-C00006.png)
HU (1) HU209308B (US07935154-20110503-C00006.png)
IE (1) IE72479B1 (US07935154-20110503-C00006.png)
IL (1) IL99213A (US07935154-20110503-C00006.png)
NO (1) NO179175C (US07935154-20110503-C00006.png)
NZ (1) NZ239495A (US07935154-20110503-C00006.png)
PT (1) PT98731B (US07935154-20110503-C00006.png)
TW (1) TW225536B (US07935154-20110503-C00006.png)
ZA (1) ZA916642B (US07935154-20110503-C00006.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0498011T3 (da) * 1991-02-07 1995-07-03 Heumann Pharma Gmbh & Co Nye salte af 2-(2,6-dichloranilino)-phenyleddikesyre, fremgangsmåde til fremstilling af disse salte og saltenes anvendelse som topisk anvendelse farmaceutiske præparater
FR2708611B1 (fr) * 1993-07-29 1995-10-27 Meram Lab Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
EP1017696B1 (de) * 1997-09-25 2002-03-20 LTS Lohmann Therapie-Systeme AG Säureadditionssalze von morphin-alkaloiden und deren verwendung
CN1514729B (zh) * 2001-06-05 2012-09-05 控制释放系统公司 缓释的止痛化合物
AU2002350207A1 (en) * 2001-11-19 2003-06-10 Control Delivery Systems, Inc. Topical delivery of codrugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
WO2004004693A1 (en) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
ES2653568T3 (es) * 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
US20090291121A1 (en) * 2008-05-23 2009-11-26 Symrise, Inc. Capsule and coated capsules as a delivery system for dietary supplements and therapeutic materials
BRPI1006222A2 (pt) 2009-03-12 2016-08-02 Cumberland Pharmaceuticas Inc uso de ibuprofeno na redução de dor em pacientes humanos que são submetidos a cirurgia, uso de ibuprofeno na redução de dor cirúrgica em pacientes humanos e uso de ibuprofeno para melhorar o tempo ambulatorial após a operação em pacientes humanos que sorem procedimentos cirúrgicos ortopédicos
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10765634B2 (en) 2012-01-24 2020-09-08 University of Pittsburgh—of the Commonwealth System of Higher Education Controlled release formulations for the induction and proliferation of blood cells
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA537946A (en) * 1957-03-12 J. Lewenstein Mozes Process for preparing improved compounds having narcotic effect
US936254A (en) * 1908-01-06 1909-10-05 Belden Mfg Co Attachment for telephones.
DE377588C (de) * 1922-08-29 1923-06-22 O Hinsberg Dr Verfahren zur Darstellung einer salzartigen Verbindung des Codeins
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US3895063A (en) * 1965-04-08 1975-07-15 Ciba Geigy Corp Substituted Anilino Benzyl Alcohols
FR2051482B1 (US07935154-20110503-C00006.png) * 1969-04-04 1973-06-08 Rabot Ets David
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
FR2257606B1 (US07935154-20110503-C00006.png) * 1974-01-10 1978-02-24 Sumitomo Chemical Co
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
NO913295L (no) 1992-02-24
FI96421C (fi) 1996-06-25
PT98731A (pt) 1992-07-31
NO179175C (no) 1996-08-21
JPH04257587A (ja) 1992-09-11
FI913949A0 (fi) 1991-08-21
NO913295D0 (no) 1991-08-22
ZA916642B (en) 1992-04-29
EP0472501A2 (de) 1992-02-26
ATE137753T1 (de) 1996-05-15
GR3019872T3 (en) 1996-08-31
HUT60501A (en) 1992-09-28
IE72479B1 (en) 1997-04-23
HU209308B (en) 1994-04-28
EP0472501A3 (en) 1993-02-24
EP0472501B1 (de) 1996-05-08
HU912768D0 (en) 1992-01-28
IE912973A1 (en) 1992-02-26
DK0472501T3 (da) 1996-05-28
CA2049649A1 (en) 1992-02-24
AU652951B2 (en) 1994-09-15
IL99213A (en) 1995-07-31
NZ239495A (en) 1997-05-26
KR920004391A (ko) 1992-03-27
AU8268591A (en) 1992-02-27
FI96421B (fi) 1996-03-15
TW225536B (US07935154-20110503-C00006.png) 1994-06-21
DE59107784D1 (de) 1996-06-13
IL99213A0 (en) 1992-07-15
US5190947A (en) 1993-03-02
PT98731B (pt) 1999-01-29
FI913949A (fi) 1992-02-24
NO179175B (no) 1996-05-13

Similar Documents

Publication Publication Date Title
ES2086515T3 (es) Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos.
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES521082A0 (es) Procedimiento para la preparacion de derivados de acido salicilico.
SE8005712L (sv) Polyprenylkarboxylsyraamider, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande dessa foreningar
ES2069915T3 (es) Dicarbonatos y uretanos de los acidos 4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilicos que tienen actividades terapeuticas.
ZA882854B (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation,their use as medicaments and pharmaceutical preparations
PT88074A (pt) Processo para a preparacao de antagonistas de leucotrieno e de composicoes farmaceuticas que os contem
DE3068456D1 (en) 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation
ES508757A0 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"
ZA828127B (en) Pyridazinone-imines and their physiologically tolerated acid addition salts, their preparation, and therapeutic agents containing these compounds
ATE4204T1 (de) 2-(2-chlor-4-cyclopropyl-phenyl-imino)imidazolidin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
RU94013445A (ru) Новое соединение, лейстродуксин н, способ его получения и терапевтическая композиция
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 472501

Country of ref document: ES